Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Leveraging Generative Artificial Intelligence in Mobile Health Promotion Programs: A Use Case for Enhancing Tailored Messaging and Engagement in a Mobile Healthy Weight Program

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to learn if integrating a chatbot into an existing 12-week smartphone-delivered behavioral weight loss program is feasible and effective for weight loss among young adults. Researchers will compare a standard behavioral weight loss program for young adults that delivers 1-2 brief messages per day (AGILE) to the same program with a chatbot integrated into the app that will offer additional behavior change support (AGILE + Chatbot) to see if the program with the chatbot is feasible, acceptable to participants, and improves program engagement and weight change.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 39
Healthy Volunteers: t
View:

• body mass index (BMI) of 25-45 kg/m\^2

• English-speaking and writing

• own an iPhone with a data plan

• willing to be randomized to either treatment group

• willing to attend one study visit at research clinic in Chapel Hill, North Carolina

Locations
United States
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Contact Information
Primary
Brooke T Nezami, PhD
bnezami@unc.edu
919-966-5852
Backup
Karen Hatley, MPH
keericks@email.unc.edu
919-966-5852
Time Frame
Start Date: 2026-03-23
Estimated Completion Date: 2026-07-20
Participants
Target number of participants: 20
Treatments
Experimental: Core Intervention
Participants receive the standard AGILE behavioral weight loss intervention via the study smartphone application.
Experimental: Core Intervention with Chatbot
Participants receive the standard AGILE behavioral weight loss intervention via the study smartphone application plus a chatbot integrated into the app.
Related Therapeutic Areas
Sponsors
Leads: University of North Carolina, Chapel Hill
Collaborators: UNC Gillings School of Global Public Health

This content was sourced from clinicaltrials.gov